What is the ROCE (Return on Capital Employed) of MedMira this year?
The ROCE of MedMira is 0.13 undefined this year.
MedMira ROCE 2024
MedMira ROCE
0.13
Ticker
MIR.V
ISIN
CA58501R1029
WKN
932414
In 2024, MedMira's return on capital employed (ROCE) was 0.13, a 9.98% increase from the 0.12 ROCE in the previous year.
MedMira Aktienanalyse
What does MedMira do?
MedMira Inc. is a Canadian company specializing in the development and marketing of innovative diagnostic products. It was founded in 1993 and is headquartered in Halifax, Nova Scotia. MedMira initially focused on HIV testing and developed the first rapid test kits, which proved to be highly effective and reliable. The company later expanded its product line to include diagnostics for Hepatitis and Syphilis. MedMira has become a leading provider of rapid test kits for infectious diseases, with its products being sold globally and proven to be reliable and effective in numerous studies. The company is constantly seeking new technologies and methods to expand its offerings and provide better solutions to its customers. MedMira's business model revolves around the development and marketing of diagnostic products for the medical and pharmaceutical markets. The company collaborates with leading companies and institutions in the industry to develop new products and improve existing solutions. MedMira has different divisions focused on its various diagnostic products, such as HIV, Hepatitis, and Syphilis. Each division has a dedicated team of experts focused on developing and marketing solutions tailored to meet customer needs. The company offers a wide range of products tailored to the needs of different customers and markets, including rapid test kits, ELISA kits, and other diagnostic tools. It specializes in serving specific target groups, such as pregnant women or newborns, and constantly strives to deliver better results to its customers. One example of a product from MedMira is the Reveal G4 Combo Rapid HIV-Syphilis Test, a highly accurate rapid test that detects both HIV and Syphilis infections. The test can be conducted quickly and provides results comparable to traditional tests. MedMira prides itself on being an innovative company focused on customer needs and constantly seeking new ways to improve diagnostics. It has built an excellent reputation and enjoys the trust of leading companies and institutions in the medical and pharmaceutical sectors. MedMira ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling MedMira's Return on Capital Employed (ROCE)
MedMira's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing MedMira's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
MedMira's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in MedMira’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about MedMira stock
How has the ROCE (Return on Capital Employed) of MedMira developed compared to the previous year?
The ROCE of MedMira has increased by 9.98% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of MedMira?
A high Return on Capital Employed (ROCE) indicates that MedMira has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of MedMira?
A low ROCE (Return on Capital Employed) can indicate that MedMira has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from MedMira impact the company?
An increase in the ROCE of MedMira can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of MedMira affect the company?
A decrease in ROCE of MedMira can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of MedMira?
Some factors that can affect MedMira's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of MedMira so important for investors?
The ROCE of MedMira is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can MedMira take to improve the ROCE?
To improve the ROCE, MedMira can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does MedMira pay?
Over the past 12 months, MedMira paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MedMira is expected to pay a dividend of 0 CAD.
What is the dividend yield of MedMira?
The current dividend yield of MedMira is .
When does MedMira pay dividends?
MedMira pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MedMira?
MedMira paid dividends every year for the past 0 years.
What is the dividend of MedMira?
For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.
In which sector is MedMira located?
MedMira is assigned to the 'Health' sector.
Wann musste ich die Aktien von MedMira kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MedMira from 11/16/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 11/16/2024.
When did MedMira pay the last dividend?
The last dividend was paid out on 11/16/2024.
What was the dividend of MedMira in the year 2023?
In the year 2023, MedMira distributed 0 CAD as dividends.
In which currency does MedMira pay out the dividend?
The dividends of MedMira are distributed in CAD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von MedMira
Our stock analysis for MedMira Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MedMira Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
